Rimegepant: Pharmacodynamic Properties, Pharmacokinetic Properties and Drug Interactions
Rimegepant is a small molecule inhibitor of CGRP receptor that blocks the action of CGRP, a potent vasodilator believed to play a role in migraine headaches.
May 9，2025 Drugs
Synthetic method and application research of Palmitoyl tripeptide-5
Palmitoyl tripeptide-5 (Pal-L-Lys-L-Val-L-Lys) is a commonly used skincare ingredient that is known for its impressive anti-aging effects.
May 8，2025 Chemical pesticides 
Ipriflavone: Pharmacokinetics, Mechanisms of Action and safety
Ipriflavone, an isoflavone, holds great promise in the prevention and treatment of osteoporosis and other metabolic bone diseases.
May 8，2025 Drugs
Amiodarone hydrochloride: Mechanism, Pharmacokinetic Properties and Photosensitivity
Amiodarone hydrochloride is a class III antiarrhythmic medication that is commonly used for the treatment of atrial arrhythmias and ventricular arrhythmias.
May 8，2025 Drugs
Synthesis of N-phenylanthranilic Acid and Its Related Toxicity and Biomarker Studies
This article covers the synthesis of N-phenylanthranilic acid, its impact on rats as a chloride channel blocker, and related biomarker studies.
May 8，2025 Pharmaceutical intermediates
Repaglinide: Characteristics, Mechanism, and Use in Type 2 Diabetes Mellitus
Repaglinide is commonly used to help lower blood sugar levels in people with type 2 diabetes and can be used for other conditions as determined.
May 8，2025 API
Lamotrigine: Applications in Bipolar Disorder Maintenance and Epilepsy Treatment
Lamotrigine is a medicine that is used to manage certain types of seizures or bipolar disorder and most common side effects of lamotrigine are dizziness.
May 8，2025 API
The pharmacological effects of Oridonin: anti-inflammasome activity and anticancer activity
Oridonin has been confirmed to exhibit many kinds of biological activities including anticancer, anti-inflammation, antibacterial and so on.
May 8，2025 Plant extracts
Sitagliptin phosphate: Mechanism,Pharmacokinetics and Pharmacodynamics
Sitagliptin phosphate, the first dipeptidyl peptidase 4 (DPP-4) inhibitor, provides a new treatment option for patients with type 2 diabetes.
May 8，2025 Pharmaceutical intermediates
Lewis structure of Potassium bromide
The Lewis structure of KBr is composed of a potassium positive (K+) ion and a bromine negative ion (Br+), where the bromine ion carries 4 lone pairs of electrons, and the two ions are surrounded by "[
May 7，2025 API